Author： Mapel Douglas W.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.28, Iss.9, 2010-09, pp. : 733-749
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
N-acetylcysteine beneficial in COPD exacerbations
Inpharma, Vol. 1, Iss. 1494, 2005-01 ,pp. :
Access to resources
Recommend
Levofloxacin, clarithromycin comparable in COPD exacerbations
Inpharma, Vol. 1, Iss. 1473, 2005-01 ,pp. :
Counting the cost of asthma exacerbations
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 345, 2002-01 ,pp. :
Long-Acting -Agonists in the Treatment of Acute Exacerbations of COPD
By Cazzola M.
Clinical Drug Investigation, Vol. 22, Iss. 6, 2002-06 ,pp. :
Home-supported discharge for COPD exacerbations cuts costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 297, 2001-01 ,pp. :